Interferon-γ modulates human oligodendrocyte susceptibility to Fas- mediated apoptosis

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 4, 2000, Pages 280-286

  Pouly, Sandrine ^a   Becher, Burkhard ^a   Blain, Manon ^a   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cytotoxicity; Fas, Human; IFN ; Oligodendrocytes; TNF

Indexed keywords

ALPHA INTERFERON; FAS ANTIGEN; GAMMA INTERFERON; MYELIN BASIC PROTEIN;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; DEMYELINATION; HUMAN; HUMAN CELL; LIGAND BINDING; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0034069944     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.4.280     Document Type: Review

References (33)

1. Panitch HS, Hirsch RL, Haley AS, Johson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987;1:893-95
2. Horwitz, MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MB. Primary demyelination in transgenic mice expressing interferon-gamma. Nat Med 1997;3:1037-41
3. Renno T, Taupin V, Bourbonniere L, et al. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci 1998;12:376-89
4. Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1995;1:732-43
5. Baerwald KD, Popko B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res 1998;52:230-39
6. Loughlin AJ, Honegger P, Woodroofe MN, Comte V, Matthieu J-M, Cuzner ML. Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment. J Neurosci Res 1994;37: 647-53
7. Smith ME. Phagocytosis of myelin in demyelinative disease: A review. Neurochem Res 1999;24:261-68
8. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes. Apoplosis induced by lymphotoxin. J Immunol 1991;147:1522-29
9. Agresti C, D'Urso D, Levi G. Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 1996;8:1106-16
10. Bonetti B, Raine CS. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 1997;42:74-84
11. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997;149:1-11
12. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8
13. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998;254: 439-59
14. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331-67
15. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 1996;184:1513-18
16. Okuda Y, Bernard CC, Fujimura H, Yanagihara T, Sakoda S. Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis. Mol Immunol 1998;35:317-26
17. Malipiero U, Frei K, Spanaus KS, et al. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas-and Fas ligand-deficient 1pr and gld mice. Eur J Immunol 1997;27:3151-60
18. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 1985;318:665-67
19. Andrews T, Zhang P, Bhat NR. TNFalpha potentiates IFN-γ-induced cell death in oligodendrocyte progenitors. J Neurosci Res 1998;54:574-83
20. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994;94:954-64
21. Becher B, D'Souza S, Troutt AB, Antel JP. Fas expression on human fetal astrocytes without susceptibility to Fas-mediated cytotoxicity. Neuroscience 1998;84:627-34
22. Yong VW, Antel JP. Culture of glial cells from human brain biopsies. In: Fedoroff S, Richardson A, eds. Protocols for neural cell culture. Totowa, New Jersey: Humana Press, 1996:157-73
23. Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW. Biology of adult human microglia in culture: Comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol 1992;51:538-49
24. Ulvestad E, Williams K, Mork S, Antel J, Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J Neuropathol Exp Neurol 1994;53:492-501
25. Ulvestad E, Williams K, Bo L, Trapp B, Antel J, Mork S. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology 1994;82:535-41
26. Prat A, Biernacki K, Becher B, Antel JP. B7 expression and antigen presentation by human brain endothelial cells: Requirement for proinflammatory cytokines. J Neuropathol Exp Neurol 2000;59:129-136
27. Windhagen A, Nicholson LB, Weiner HL, Kuchroo VK. Hafler DA. Role of Th1 and Th2 cells in neurologic disorders. Chem Immunol 1996;63:171-86
28. Chen D, Borson ND, Courtney R, Rodriguez M, Hunter SF. Rapid down-regulation of myelin gene protein messages in mature brain oligodendrocytes by interferon-gamma using direct measurement with quantitative RT-PCR. Soc Neurosci Abstr 1999;25(1):483
29. D'Souza S, Bonetti B, Balasingam V, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996;184: 2361-70
30. Waldner H, Sobel RA, Howard E, Kuchroo VK. Fas-and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997;159:3100-3103
31. Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell JH. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 1997;159:3096-99
32. Elliott EA, McFarland HI, Nye SH, et al. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 1996;98: 1602-12
33. Clark RB, Grunnet M, Lingenheld EG. Adoptively transferred EAE in mice bearing the lpr mutation. Clin Immunol Immunopathol 1997;85:315-19